Poly(lactic-co-glycolic acid) (PLGA) nanoparticle-encapsulating medications, like doxorubicin, block the AKT/mTOR pathway, hence inducing autophagy and increasing cancer cell susceptibility to treatment [67]. Here, AKT1 is linked to cancer.